Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objectives: There is limited evidence supporting the widespread use of α2 agonists (clonidine and dexmedetomidine) in pediatric critical care sedation. This study sought to test the association between the use of α2 agonists and enhanced sedation. Design: A retrospective observational cohort study was conducted. Noninferiority of time adequately sedated (COMFORT Behavior Score 11–16) while mechanically ventilated was assessed. Secondarily, dosing of opioids and benzodiazepines was examined. Setting: Two tertiary PICUs. Patients: Children were classified into an exposed group, who received an α2 agonist as part of their sedation regimen, and an unexposed group. Groups were matched using propensity score analysis. Interventions: None. Measurements and Main Results: One-thousand eighty-five patients were included. The exposed group were adequately sedated 74% (95% CI, 72–75%) of the study time compared with the unexposed group at 70% (95% CI, 67–72%) giving a ratio of 1.06 (95% CI, 1.02–1.10) and a noninferior time adequately sedated. A decrease in time oversedated was observed with 8.1% (95% CI, 4.3–11.9%) less time classified as oversedated in the exposed group. Reduction in morphine use of 0.25 μg/kg/hr (95% CI, –0.68 to 1.18 μg/kg/hr) was not statistically significant. Midazolam use did not decrease and was statistically higher. Conclusions: Use of α2 agonists was associated with similar time adequately sedated as a matched unexposed group although no reduction in morphine or benzodiazepine coadministration was observed. There was a shift toward lighter sedation with α2 agonist use.
Objectives: There is limited evidence supporting the widespread use of α2 agonists (clonidine and dexmedetomidine) in pediatric critical care sedation. This study sought to test the association between the use of α2 agonists and enhanced sedation. Design: A retrospective observational cohort study was conducted. Noninferiority of time adequately sedated (COMFORT Behavior Score 11–16) while mechanically ventilated was assessed. Secondarily, dosing of opioids and benzodiazepines was examined. Setting: Two tertiary PICUs. Patients: Children were classified into an exposed group, who received an α2 agonist as part of their sedation regimen, and an unexposed group. Groups were matched using propensity score analysis. Interventions: None. Measurements and Main Results: One-thousand eighty-five patients were included. The exposed group were adequately sedated 74% (95% CI, 72–75%) of the study time compared with the unexposed group at 70% (95% CI, 67–72%) giving a ratio of 1.06 (95% CI, 1.02–1.10) and a noninferior time adequately sedated. A decrease in time oversedated was observed with 8.1% (95% CI, 4.3–11.9%) less time classified as oversedated in the exposed group. Reduction in morphine use of 0.25 μg/kg/hr (95% CI, –0.68 to 1.18 μg/kg/hr) was not statistically significant. Midazolam use did not decrease and was statistically higher. Conclusions: Use of α2 agonists was associated with similar time adequately sedated as a matched unexposed group although no reduction in morphine or benzodiazepine coadministration was observed. There was a shift toward lighter sedation with α2 agonist use.
НИИ хирургии детского возраста ФГБОУ ВПО «РНИМУ им. Н. И. Пирогова» МЗ РФ, Москва, Россия 2 ФГБОУ ВО «Башкирский государственный медицинский университет» МЗ РФ, г. Уфа, Россия 3 ФГБОУ ВО «Уральский государственный медицинский университет» МЗ РФ, г. Екатеринбург, Россия 4 ФГБУ «Национальный медицинский исследовательский центр хирургии им. А. В. Вишневского» МЗ РФ, Москва, Россия Обзор литературы посвящен одной из актуальных проблем современной интенсивной терапии-диагностике сепсиса у детей� В обзоре освещены современное определение понятия «сепсис» и критический анализ публикаций по педиатрическому сепсису за последние годы� Рассмотрены преимущества и недостатки подхода рекомендаций «Сепсис-3» в педиатрической интенсивной терапии� Особое внимание уделено возможностям методам раннего выявления и оценки тяжести органной дисфункции у детей с инфекцией посредством специальных шкал pSOFA или PELOD-2�
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.